Etiopathogenetic mechanisms of fibromyalgia syndrome.

@article{Stisi2008EtiopathogeneticMO,
  title={Etiopathogenetic mechanisms of fibromyalgia syndrome.},
  author={Stefano Stisi and Marco Cazzola and Dan Buskila and Marian Spath and Maria Adele Giamberardino and Piercarlo Sarzi-Puttini and Giovanni Arioli and Alessandra Alciati and Gianni Leardini and R. M. Adri{\'a}n Gorla and Antonio Domenico Marsico and Francesco Ceccherelli and Laura Maria Bazzichi and Renato Carignola and Richard H. Gracely and Fausto Salaffi and Franco Marinangeli and Riccardo G. V. Torta and Manuela Di Franco and Giovanni Biasi and Giannantonio Cassisi and Roberto Casale and Lorenzo Altomonte and Fabiola Atzeni},
  journal={Reumatismo},
  year={2008},
  volume={60 Suppl 1},
  pages={
          25-35
        }
}
Fibromyalgia syndrome (FMS) is a common chronic condition of widespread pain with causal mechanisms that are largely unknown. It is characterized by moderate to severe musculoskeletal pain and allodynia, but its pathogenesis appears confined to the nociceptive structures of the central nervous system. FMS is often triggered by negative environmental influences, especially if they occur in childhood. In a fetus, these environmental triggers may influence the development of the autonomic nervous… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS

Combined therapy (ultrasound and interferential current) in patients with fibromyalgia: once or twice in a week?

  • Physiotherapy research international : the journal for researchers and clinicians in physical therapy
  • 2012
VIEW 2 EXCERPTS
CITES BACKGROUND

Fibromyalgia Syndrome: Etiology, Pathogenesis, Diagnosis, and Treatment

  • Pain research and treatment
  • 2012
VIEW 2 EXCERPTS
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 110 REFERENCES

The promise of substance P inhibitors in fibromyalgia

IJ Russell
  • Rheum Dis Clin N Am
  • 2002
VIEW 14 EXCERPTS
HIGHLY INFLUENTIAL

The promise of substance P inhibitors in fibromyalgia

IJ Russell
  • Rheum Dis Clin N Am
  • 2002
VIEW 14 EXCERPTS
HIGHLY INFLUENTIAL

Decreased central mu-opioid receptor availability in fibromyalgia.

  • The Journal of neuroscience : the official journal of the Society for Neuroscience
  • 2007
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…